Edition:
United Kingdom

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

31.09USD
17 Aug 2018
Change (% chg)

$0.37 (+1.20%)
Prev Close
$30.72
Open
$30.64
Day's High
$31.12
Day's Low
$30.59
Volume
20,628
Avg. Vol
55,354
52-wk High
$32.89
52-wk Low
$14.89

Chart for

About

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $804.79
Shares Outstanding(Mil.): 34.33
Dividend: --
Yield (%): --

Financials

  ATRC.OQ Industry Sector
P/E (TTM): -- 32.29 32.76
EPS (TTM): -1.02 -- --
ROI: -13.17 13.92 14.61
ROE: -19.19 16.77 16.33

BRIEF-Atricure Inc Q1 Loss Per Share $0.31

* Q1 EARNINGS PER SHARE VIEW $-0.27 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

26 Apr 2018

BRIEF-Atricure Posts Q4 Loss Per Share $0.08

* ATRICURE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

26 Feb 2018

BRIEF-Atricure Inc Launches Atriclip Flex V Device In U.S.

* ATRICURE INC - ‍LAUNCHES ATRICLIP FLEX•V DEVICE IN UNITED STATES​ Source text for Eikon: Further company coverage:

22 Feb 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $134.47 +1.99
St Jude Medical Inc (STJ.N) -- --

Earnings vs. Estimates